8-K/AThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Oct 16, 2023 · 2y ago · Accession 0001193125-23-256865
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spero Therapeutics, Inc.
- Ticker
- SPRO
- CIK
- 1701108
- Form type
- 8-K/A
- Filing date
- Oct 16, 2023
- Report date
- Oct 5, 2023
- Document
- d563868d8ka.htm
- Size
- 163 KB